Just 30% of Americans with HIV had the virus under control in 2011, and approximately two-thirds of those whose virus was out of control had been diagnosed but were no longer in care.
Specialty Pharmacy News
Pharmaceutical sales through HDMA-member traditional primary distributors reached nearly $305 billion in 2013.
Genzyme, a Sanofi company, on Friday announced that the Food and Drug Administration approved Lemtrada (alemtuzumab) for the treatment of patients with relapsing forms of multiple sclerosis.
Walgreens earlier this week opened its first Walgreens Specialty Pharmacy in the Omaha, Neb. market.
UCB, Advent International and Avista Capital Partners last week announced they have entered into a definitive agreement providing for the acquisition of UCB’s U.S. specialty generics subsidiary, Kremers Urban Pharmaceuticals, by Advent and Avista.
Diplomat Pharmacy on Wednesday announced the addition of Martino Luu to their senior leadership team as VP innovation and process improvement.
The RAND Corp. projected that the introduction of biosimilar drugs in the United States will reduce direct spending on biologics by $44.2 billion from 2014 to 2024.
Mylan on Friday announced the launch of nevirapine extended-release tablets in 400-mg strength, a generic version of Viramune XR from Boehringer Ingelheim.
Sandoz, through its branded dermatology business PharmaDerm, and Medigene AG on Thursday announced a promotion agreement with Women's Choice Pharmaceuticals for Veregen (sinecatechins) ointment, 15% strength.
The majority of independent community pharmacists are interested in incorporating personalized medicine services into their practices, but they require further education before this is possible.